直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Firm
  • Careers
Finnegan
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • IP Health Blog
    • Prosecution First Blog
  • Articles
  • IP Updates
  • Podcasts
  • Events
  • Webinars
  • Books

At the PTAB Blog

Petitioner Estopped Due to Final Written Decisions in Parallel IPR Proceedings with Petitions Filed Simultaneously

February 15, 2022

By Troy V. Viger

Edited by Joshua L. Goldberg

In Intuitive Surgical, Inc. v. Ethicon LLC, No. 2020-1481 (Fed. Cir. Feb. 11, 2022), the Federal Circuit affirmed that Intuitive was estopped under § 315(e)(1) from maintaining an IPR and dismissed the appeal.

Intuitive simultaneously filed three IPRs challenging the patentability of Ethicon’s patent, each relying on different prior art references, yet each attacking the same claims. The Board issued final written decisions in two of the IPRs. Later, in the third, the Board removed Intuitive as a petitioner because § 315(e)(1) estopped Intuitive after issuance of the two final written decisions.

Intuitive argued § 315(e)(1) estoppel should not apply to simultaneously filed petitions. The Court rejected Intuitive’s argument that it could not “reasonably have raised” all its grounds in two IPR petitions because of word limits. The Federal Circuit also noted that Intuitive had alternative avenues that would have allowed it to file three full-length petitions while avoiding the consequences of § 315(e)(1). It could have sought consolidation or focused each petition on a separate set of claims.

Intuitive also argued it may appeal the Board’s decision because it was once a party to an IPR. The Federal Circuit concluded that once § 315(e)(1) estopped Intuitive, it ceased to be a party, and lost any right to appeal.

Tags

Patent Trial and Appeal Board (PTAB), IPR estoppel, Final Written Decision

Related Practices

Post-Grant Proceedings

IPR, PGR, and CBM

Appeals of PTAB Trial Decisions

Related Industries

Life Sciences

Medical Device and Diagnostics

Related Offices

Atlanta, GA

Washington, DC

Contacts

Troy V. Viger
Associate
Atlanta, GA
+1 404 653 6475
Email
Joshua L. Goldberg
Partner
Washington, DC
+1 202 408 6092
Email

Copyright © 2022 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

California Intellectual Property Law Institute 2022

October 17-18, 2022

San Francisco

Conference

New York Intellectual Property Law Institute 2022

September 15-16, 2022

New York

Conference

Breaking the Concrete Ceiling: How Women of Color Overcome the Invisible Barrier

June 16, 2022

Washington, DC

Webinar

Patent Drafting for Cryptocurrency Innovations: Overcoming Eligibility Challenges, Minimizing the Risks of Rejection

June 14, 2022

Webinar

Virtual Seminar

13th Annual Ethics in the Practice of IP Law

June 10, 2022

Virtual

Conference

Diversity, Equity, and Inclusion Summit

June 10, 2022

Virtual

Seminar

Practical Tips: European and US IP Practice Seminar

June 9, 2022

London

Webinar

Manufacturing Monetization: Due Diligence Before Licensing or Litigating Your Patent Portfolio

June 8, 2022

Webinar

Charitable

Bridges from School to Work Gala 2022

June 8, 2022

Washington, DC

Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.

We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.

  • Privacy
  • Disclaimer
  • EEO Statement

© 2022 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP